Search

Your search keyword '"K. A. Apartsin"' showing total 50 results

Search Constraints

Start Over You searched for: Author "K. A. Apartsin" Remove constraint Author: "K. A. Apartsin" Database OpenAIRE Remove constraint Database: OpenAIRE
50 results on '"K. A. Apartsin"'

Search Results

1. Design of organyl phosphate-based pro-drugs: comparative analysis of the antibiotic action of alkyl protecting groups with different degree of fluorination

4. The Frequency of the Minor Polymorphisms in the CYP2C19, VEGFR-2 Genes, and Clinical Outcomes in Russian and Buryat Patients with Acute Coronary Syndrome

5. Oxidative Cross-Coupling of Cysteamine with Secondary Phosphine Chalcogenides: Aspects of Reaction Chemoselectivity

6. Cationic copolymerization of cholesterol vinyl ether with methylvinylsulfide: toward medicinal polymers

7. Cationic Copolymerization of Cholesterol Vinyl Ether with Methyl Vinyl Sulfide: Towards New Biologically Active Oligomers

8. Cationic copolymerisation of cholesterol vinyl ether with N-allenylpyrrolidone; a route to pharmacologically promising oligomers

10. Synthesis, characterization and biological evaluation of Zn(II) and Co(II) complexes of N-allylimidazole as potential hypoxia-targeting agents

11. Synthesis and antimicrobial activity of new phosphorus-containing pyridine derivatives

12. Regional aspects of associations of the CYP2C19 gene polymorphism with coronary atherosclerosis in acute coronary syndrome

13. Features of the topographic anatomy of the rat trachea and the possibility of performing surgical interventions

14. ASSESSMENT OF INDICES OF NONSPECIFIC RESISTANCE OF THE ORGANISM IN CONDITIONS OF NARROWING OF THE LUMEN OF THE TRACHEA IN AN EXPERIMENT

15. Metal-free addition of aliphatic carboxylic acids to cyanopropargyl alcohols: an access to new families of functionalized dihydrofurans and 3(2H)-furanones

16. Prospective multicenter observational the personalized therapy with clopidogrel for stenting in acute coronary syndrome regarding the genetic polymorphisms (PROTOCOL) study

17. Circulating free DNA in hypertensive patients with high cardiovascular risk

18. EVIDENCE BASED MEDICINE IN SPLENIC DISEASES

19. The frequency of CYP2C19 allelic variants in patients with acute coronary syndrome in Central, Eastern, Northern Siberia and Moscow region

20. MITOCHONDRIAL DYSFUNCTION AT ATHEROSCLEROSIS AND MYOCARDIAL INFARCTION: MOLECULAR AND CYTOCHEMICAL CELL-MARKERS

21. A Method for Microencapsulation of Cells and a Device for Its Realization

22. Convalescent fecal microbiota transplantation as a possible treatment for COVID-19

23. DBU as a scaffold for the synthesis of [1,3]oxazolo[2 ’ ,3 ’ : 2,3]pyrimido-[1,2- a ]azepines: annulation with aromatic cyanopropargylic alcohols

25. Furfuryl vinyl ethers in [4+2]-cycloaddition reactions

26. Measurement of Hemostasis Parameters: Equipment and Potential for Development

27. ASSOCIATION OF THE GENE CYP11B2 WITH THE RISK OF ESSENTIAL HYPERTENSION AND ATHEROTHROMBOTIC COMPLICATIONS

28. EFFECT OF SINGLE INTAKE OF EXOGENOUS HEPATOCYTES GROWTH INDUCER ON THE INDICES OF NON-SPECIFIC RESISTANCE UNDER CONDITIONS OF POSTRESECTION LIVER INJURY

29. ANTI-INFLAMMATORY ACTIVITY OF A ZINC-CONTAINING COMPOSITE IN THE PRESENCE OF SIMULATED ULCERATIVE COLITIS

30. Synthesis and properties of a new family of phosphorus- and nitrogen-containing ionenes

31. Level of blood cell-free circulating mitochondrial DNA as a novel biomarker of acute myocardial ischemia

32. Department of Biomedical Research and Technologies of the Irkutsk Scientific Center of the SBRA Sprerequisites for the creation and direction of work (editorial)

33. Intermediate results 2016 of a search study of translational diagnostic methods Mitochondrial dysfunction in patients with chronic myocardial ischemia and/or head Brain

34. Association of polymorphisms Gene CYP2C19 with endpoints of efficacy and safety of clopidogrel therapy And platelet aggregation in patients with acutecoronary syndrome study Protocol

35. Advantages of a personalized approach to the prevention and treatment of cardiovascular diseases in the staff of the INC Of the SBRAS

36. ENDOTHELIAL DYSFUNCTION AS CORNERSTONE OF CARDIOVASCULAR EVENTS: MOLECULAR AND PHARMACEUTIC ASPECTS

37. INVENTIVE WORK OF SCIENTIFIC CENTER OF RECONSTRUCTIVE AND RESTORATIVE SURGERY SB RAMS (REPORT 2)

38. Inventive activity of Scientific Center of Reconstructive and Restorative Surgery SB RAMS (report 1)

39. Acute myocardial ischemia: changes of free circulating mtDNA level in blood after occlusion of the upper one-third left descending branch of the coronary artery

40. Differentiated approach to cell correction of acute hepatic failure at the acute toxic injury. Morphological basis of choosing the way of treatment

41. EVALUATION OF EFFICIENCY AND SAFETY OF THROMBOPROPHYLAXIS AFTER ORTHOPEDIC OPERATIONS

42. Unexpected Carbon–Selenium Bond Formation in the Reaction of Secondary Phosphine Selenides with Benzoylphenylacetylene

43. Étude comparant le fondaparinux à une héparine de bas poids moléculaire dans la prévention de la maladie thromboembolique veineuse en cas d’immobilisation rigide ou semi-rigide après traumatisme isolé non chirurgical du membre inférieur au-dessous du genou

44. [Pathophysiological mechanisms of bacterial endotoxicosis in disseminated peritonitis]

45. THE 'PROTOCOL' STUDY: PRELIMINARY RESULTS

47. [Staged correction of surgical pathology of the stomach ('Damage Control') in conditions of decompensated hypovolemic shock]

49. Expediency of Trauma Center System Development in Oblasts of Siberian Federal Region: Monitoring Results of Concomitant Injury

50. The level of free circulating mitochondrial DNA in blood as predictor of death in case of acute coronary syndrome

Catalog

Books, media, physical & digital resources